Another plausible mechanism is that hyperglycemia affects NF-κb, a key mediator that regulates multiple proinflammatory and proatherosclerotic target genes in endothelial cells, vascular smooth muscle cells, and macrophages (47). This evidence concerns the gene NFKB1 and Hyperglycemia.